COGNITION THERAPEUTICS INC (CGTX) Stock Cash Flow
NASDAQ:CGTX - Nasdaq - US19243B1026 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -33.30M | -33.97M | -25.79M | -21.40M | -11.72M | |||
| Depreciation Amortization | 262.00K | 266.00K | 252.00K | 80.00K | 90.00K | |||
| Change In Working Capital | -1.22M | 1.29M | 4.85M | -940.00K | 2.84M | |||
| Other non cash items | 3.15M | 3.94M | 4.67M | 3.72M | 5.15M | |||
| OPERATING CASH FLOW | -31.11M | -28.47M | -16.02M | -18.53M | -3.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -4.00K | -147.00K | -170.00K | -30.00K | |||
| INVESTING CASH FLOW | N/A | -4.00K | -147.00K | -170.00K | -30.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -679.00K | -739.00K | -811.00K | -1.40M | -270.00K | |||
| Stock Issued/Repurchased | 14.00M | 24.43M | 5.33M | 6.94M | 44.53M | |||
| Other Financing Activity | -449.00K | -128.00K | N/A | 0.00 | 8.94M | |||
| FINANCING CASH FLOW | 12.87M | 23.57M | 4.52M | 5.55M | 53.20M | |||
| Exchange Rate Effect | N/A | N/A | 4.00K | 0.00 | -10.00K | |||
| CHANGE IN CASH | -18.24M | -4.91M | -11.64M | -13.15M | 49.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -31.11M | -28.47M | -16.02M | -18.53M | -3.63M | |||
| Capital Expenditure | N/A | -4.00K | -147.00K | -170.00K | -30.00K | |||
| FREE CASH FLOW | -31.11M | -28.48M | -16.16M | -18.70M | -3.66M | |||
All data in USD